- Home
- OXSQ vs NRXP Comparison
OXSQ vs NRXP Comparison
Compare OXSQ & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OXSQ | NRXP |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.7M | 151.1M |
| IPO Year | 2003 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OXSQ | NRXP |
|---|---|---|
| Price | $1.31 | $2.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $38.50 |
| AVG Volume (30 Days) | ★ 1.1M | 660.5K |
| Earning Date | 11-03-2026 | 11-16-2026 |
| Dividend Yield | ★ 31.58% | N/A |
| EPS Growth | N/A | ★ 69.70 |
| EPS | ★ 0.10 | N/A |
| Revenue | N/A | ★ $1,225,000.00 |
| Revenue This Year | N/A | $357.94 |
| Revenue Next Year | $10.39 | $1,507.30 |
| P/E Ratio | $13.25 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.05 | $1.65 |
| 52 Week High | $2.05 | $5.06 |
Technical Indicators
Market Signals| Indicator | OXSQ | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 50.03 | 29.50 |
| Support Level | $1.30 | $1.68 |
| Resistance Level | $1.42 | $2.49 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 40.00 | 30.61 |
Price Performance
Historical ComparisonAbout OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize portfolio's total return. Its primary current focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and, to a lesser extent collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. CLO investments may also include warehouse facilities, which are early-stage CLO vehicles intended to aggregate loans that may be used to form the basis of a traditional CLO vehicle. The company may also invest in publicly traded debt and/or equity securities.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.